268 related articles for article (PubMed ID: 31375867)
21. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors.
Sasada S; Kimura Y; Masumoto N; Emi A; Kadoya T; Arihiro K; Okada M
Eur J Surg Oncol; 2021 Jul; 47(7):1588-1592. PubMed ID: 33685728
[TBL] [Abstract][Full Text] [Related]
22. Avoiding Overtreatment of Ductal Carcinoma in situ.
van der Borden CL; Stoffers S; Lips EH; Wesseling J
Trends Cancer; 2019 Jul; 5(7):391-393. PubMed ID: 31311652
[TBL] [Abstract][Full Text] [Related]
23. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
24. Computer-aided heterogeneity analysis in breast MR imaging assessment of ductal carcinoma in situ: Correlating histologic grade and receptor status.
Chou SS; Gombos EC; Chikarmane SA; Giess CS; Jayender J
J Magn Reson Imaging; 2017 Dec; 46(6):1748-1759. PubMed ID: 28371110
[TBL] [Abstract][Full Text] [Related]
25. Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
Alaeikhanehshir S; Voets MM; van Duijnhoven FH; Lips EH; Groen EJ; van Oirsouw MCJ; Hwang SE; Lo JY; Wesseling J; Mann RM; Teuwen J;
Cancer Imaging; 2024 Apr; 24(1):48. PubMed ID: 38576031
[TBL] [Abstract][Full Text] [Related]
26. Breast scintigraphy with breast-specific γ-camera in the detection of ductal carcinoma in situ: a correlation with mammography and histologic subtype.
Spanu A; Sanna D; Chessa F; Cottu P; Manca A; Madeddu G
J Nucl Med; 2012 Oct; 53(10):1528-33. PubMed ID: 22911882
[TBL] [Abstract][Full Text] [Related]
27. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
Grimm LJ; Ghate SV; Hwang ES; Soo MS
Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
[TBL] [Abstract][Full Text] [Related]
28. Ductal carcinoma in situ (DCIS) in Karachi.
Kayani N; Bhurgri Y
J Pak Med Assoc; 2005 May; 55(5):199-202. PubMed ID: 15960285
[TBL] [Abstract][Full Text] [Related]
29. Ductal carcinoma in situ: Is core needle biopsy ever enough?
Caswell-Smith P; Wall M
J Med Imaging Radiat Oncol; 2017 Feb; 61(1):29-33. PubMed ID: 27554420
[TBL] [Abstract][Full Text] [Related]
30. Sonographic findings of high-grade and non-high-grade ductal carcinoma in situ of the breast.
Park JS; Park YM; Kim EK; Kim SJ; Han SS; Lee SJ; In HS; Ryu JH
J Ultrasound Med; 2010 Dec; 29(12):1687-97. PubMed ID: 21098839
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological Features of Ductal Carcinoma
Fujii T; Yanai K; Tokuda S; Nakazawa Y; Kurozumi S; Obayashi S; Yajima R; Hirakata T; Kuwano H
Anticancer Res; 2017 Sep; 37(9):5053-5056. PubMed ID: 28870933
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Kim JS; Lee SM; Cha ES
Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
[TBL] [Abstract][Full Text] [Related]
33. Pathology of ductal carcinoma in situ of the breast: a heterogeneous entity in need of greater understanding.
Tan PH
Ann Acad Med Singap; 2001 Nov; 30(6):671-6; quiz 677. PubMed ID: 11817303
[TBL] [Abstract][Full Text] [Related]
34. Histogram analysis of volume-based apparent diffusion coefficient in breast cancer.
Park GE; Kim SH; Kim EJ; Kang BJ; Park MS
Acta Radiol; 2017 Nov; 58(11):1294-1302. PubMed ID: 28273747
[TBL] [Abstract][Full Text] [Related]
35. Evolving Treatment Paradigms for Low-Risk Ductal Carcinoma In Situ: Imaging Needs.
Nguyen DL; Greenwood HI; Rahbar H; Grimm LJ
AJR Am J Roentgenol; 2024 Mar; 222(3):e2330503. PubMed ID: 38090808
[TBL] [Abstract][Full Text] [Related]
36. Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.
Kim JY; Kim JJ; Lee JW; Lee NK; Lee G; Kang T; Park H; Son YH; Grimm R
Eur Radiol; 2019 Feb; 29(2):485-493. PubMed ID: 30073498
[TBL] [Abstract][Full Text] [Related]
37. Breast Density in a Contemporary Cohort of Women With Ductal Carcinoma In Situ (DCIS).
Gooch JC; Chun J; Kaplowitz E; Kurz E; Guth A; Lee J; Schnabel F
Ann Surg Oncol; 2019 Oct; 26(11):3472-3477. PubMed ID: 31147991
[TBL] [Abstract][Full Text] [Related]
38. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast.
Hussein H; Chung C; Moshonov H; Miller N; Kulkarni SR; Scaranelo AM
Acad Radiol; 2015 Dec; 22(12):1483-8. PubMed ID: 26391856
[TBL] [Abstract][Full Text] [Related]
40. Impact of Preoperative Breast MR Imaging and MR-guided Surgery on Diagnosis and Surgical Outcome of Women with Invasive Breast Cancer with and without DCIS Component.
Kuhl CK; Strobel K; Bieling H; Wardelmann E; Kuhn W; Maass N; Schrading S
Radiology; 2017 Sep; 284(3):645-655. PubMed ID: 28445683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
